JULIA RODARTE: Open Payments
NPI 1780174904 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 26 payments from 13 companies in 2025. Trend: 2023 $734 · 2024 $866 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Abbott Laboratories | 3 | $68 |
| Amgen Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: GEMTESA, REXULTI, BREZTRI, AIRSUPRA, PROCLAIM, Wegovy, ZORYVE, OTEZLA.
Industry payments across AZ — which companies pay providers there.
